marijuana stock news

Form 8-K for CARA THERAPEUTICS, INC.


9-Jun-2015

Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders.On June 8, 2015, Cara Therapeutics, Inc. (the “Company”) held its 2015 Annual Meeting of Stockholders (“Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the two proposals set forth below. A more detailed description of each proposal is set forth in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 24, 2015.

Proposal 1 – Election of Directors

Mr. Harrison M. Bains, Jr. was elected to serve as a director of the Company’s Board of Directors until the 2018 Annual Meeting of Stockholders and until his successor is duly elected or until his earlier resignation or removal, by the following votes:

Nominee Votes For Votes Withheld Broker Non-Votes Harrison M. Bains, Jr. 11,412,603 84,891 5,087,184

Proposal 2 – Ratification of the Selection of Independent Registered Public Accounting Firm

The stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2015, by the following votes:

Votes For Votes Against Votes Abstain 16,278,064 300,964 5,650


 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$LXRP Design Phase Underway for Studies to be Conducted

Design Phase Underway for Studies to be Conducted by National Research Council…

$NTRR Develops Customer Awareness at CannaCon

NTRR Builds Customer Awareness at CannaCon Neutra Corp. (NTRR) representatives attended last…

HEXO Corp (HEXO) to Participate in Canaccord Genuity’s 5th Annual Global Cannabis

HEXO Corp to Participate in Canaccord Genuity’s 5th Annual Global Cannabis HEXO…

$INSY Beats 1Q Profit Forecasts

Insys Therapeutics beats 1Q profit forecasts Insys Therapeutics posts 1Q profit of…